American Gene Technologiesainternational Inc Agtis A Clinical Stage Biotechnology Company Based In Rockvillemarylandthe Company Specializes In Gene And Cell Therapies Aimed At Treating Infectious Diseasescancersand Monogenic Disordersagt Utilizes A Proprietary Lentiviral Platform To Develop Genetic Medicines With A Focus On Curing Diseases Rather Than Providing Lifelong Treatmentskey Areas Of Focus Include Hiv Aidsphenylketonuriapku And Hepatocellular Carcinoma Agt Is Advancing Its Gene Therapy Development Through Its Lentiviral Vector Platformwhich Has Shown Promising Results In Preclinical Studiesparticularly For Hivthe Company Has Engineered Autologous Cell Therapiessuch As Agt103 Twhich Modifies T Cells To Resist Hiv Infectionagt Launched Addimmunea C In 2023 To Further Its Hiv Cure Programbuilding On Successful Phase 1 Trial Resultsadditionallyagt Is Developing Therapies For Pku And Liver Canceraiming To Restore Metabolic Functions And Target Cancer Cellsrespectivelythe Company Holds Multiple Patents For Its Technologies And Has Secured Venture Capital To Support Its Research And Development Efforts
